Wajd Al-Holou, n/a

Principal Investigator
University of Michigan, United States

Disclosure information not submitted.

Presentation(s):

• Comparative Single-Cell Sequencing of Primary Versus Recurrent Glioblastoma Defines Cellular States Associated with Therapy Resistance

  Saturday, May 4, 2024
  2:04 PM – 2:08 PM CT

• THY1 confers proliferative advantages and therapy resistance in Glioblastoma.

  Sunday, May 5, 2024
  2:49 PM – 2:51 PM CT